Treatment | Page 328 of 465

Infectious Disease :: GreeneChip – New diagnostic tool identifies multiple pathogens

Researchers in the Greene Infectious Disease Laboratory at Columbia University’s Mailman School of Public Health and their colleagues in the WHO Global Laboratory Network have developed a new tool for pathogen surveillance and discovery — the GreeneChip System. The GreeneChip is the first tool to provide comprehensive, differential diagnosis of infectious diseases, including those caused by viruses, bacteria, fungi or parasites.

November/December 2006 Annals of Family Medicine tip sheet

This tip sheet provides summaries of the studies published in the November/December issue of Annals of Family Medicine and cover topics such as antibiotic use for rhinosinusitis and sore throat, the impact of the 2004 flu vaccine shortage and other clinical topics.

Imaging :: Examining molecular imaging’s hot future

The December issue of the Journal of Nuclear Medicine carries specific conclusions and recommendations on how the medical community can harness the power of molecular imaging and therapy to manage diseases and improve the quality of life for patients. “Shaping the Future: The 2006 SNM Molecular Imaging Summit” provides the first-ever look at molecular imaging’s potential — as seen by medical professionals, scientists, industry representatives, and funding and regulatory officials — in a special expanded section of the society’s flagship journal.

Heart Disease :: Screening children for heart disease risk helps to identify parents at risk

Screening children for risk factors associated with cardiovascular disease can help identify parents at risk for the condition, providing an opportunity for medical intervention in both children and their parents, according to research at Children’s Hospital of Pittsburgh of UPMC.

Osteoporosis :: Biocompatible glass helping damaged bone regenerate

Researchers from Lehigh and Princeton Universities join with colleagues from Egypt and Portugal to take aim at osteoporosis and other bone disorders. Their goal is to tailor a biocompatible glass so it can serve as a scaffold that promotes the regrowth of damaged or diseased bone.

ADHD :: Does Omega 3 protect against ADHD?

A new study will provide further understanding about the effects of omega-3 fatty acids on the brain function of children with Attention Deficit Hyperactivity Disorder (ADHD).

Diabetes :: Glaxo’s diabetes drug beats older rivals

Diabetes patients starting out on GlaxoSmithKline drug Avandia have a better chance of keeping blood sugar levels within safe limits than those given older medicines, revealed after a clinical trial by Glaxo.

NHS :: NHS Plan for A&E cuts

UK Government has decided to reduce accident and emergency services at local hospitals and concentrate them at specialist regional centres.

Fibroid :: Combined procedure for uterine preservation in treating fibroids

Although fibroids?benign tumors that grow in the uterus?can cause pelvic pain, abnormal vaginal bleeding and infertility, women of childbearing age often choose to forego treatment because the available treatment options don?t guarantee fertility.

Stent :: Cypher Coronary stents approved for use by Health Canada

Cordis Corporation, the world’s leading drug-eluting stent manufacturer, today announced the launch of CYPHER SELECT(TM) Plus, the first third-generation drug-eluting stent available for the treatment of Canadian patients with coronary artery disease.